Wells Fargo analyst Larry Biegelsen upgraded Medtronic to Overweight from Equal Weight with a price target of $100, up from $77.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MDT:
- Medtronic Gains Ground Following Analyst Praise
- Medtronic announces FDA approval of MiniMed 780G system
- Tandem Diabetes down 5% after FDA approves Medtronic’s MiniMed 780G
- Medtronic up 3% after FDA approves expanded indication for MiniMed 780G System
- FDA approves Medtronic MiniMed 780G System for modifications